Literature DB >> 6221398

Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.

M Giorgi-Conciato, S Daniotti, P A Ferrari, M Gaetani, G Petrin, P Sala, P Valentini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6221398

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN： 0085-5928


× No keyword cloud information.
  4 in total

Review 1.  Gastric cytoprotection. What does it really mean for the prescriber?

Authors:  M Guslandi
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

2.  Blood disorders associated with pirenzepine.

Authors:  B H Stricker; R H Meyboom; P A Bleeker; K van Wieringen
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

3.  Comparison of central gastric antisecretory effects of desmethylimipramine, doxepin and pirenzepine in rats.

Authors:  R G Pendleton; M Williams; C Chung; P Cook; E Risley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

Review 4.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.